During the last decade, senile dementia and the presenile disease that
was named after Alois Alzheimer have been considered a single entity
called Alzheimer's disease (AD). This same decade has witnessed the de
velopment of many diagnostic tools, such as CT, MRI, and SPECT imaging
, that have made possible the systematic analysis of symptoms of brain
disorders. With the aid of these sophisticated techniques, it is poss
ible to divide the disorder into clinically relevant subgroups, one of
which corresponds to the disease first described by Alzheimer. The di
sease exists in sporadic and familial forms, and in subgroups of these
two basic types. Because the heterogeneity of AD is incontestable, it
is time to reconsider the current use of the term ''Alzheimer's disea
se''. Because it labels different subgroups whose characteristics are
often markedly different, the term ''Alzheimer syndrome'' appears to b
e more appropriate.